NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $871,412 | +4.6% | 8,555 | +3.6% | 1.46% | +9.2% |
| Q2 2023 | $833,012 | +13.9% | 8,255 | +3.8% | 1.34% | -0.6% |
| Q1 2023 | $731,308 | +15.3% | 7,949 | +13.7% | 1.34% | -1.8% |
| Q4 2022 | $634,133 | +5.2% | 6,990 | -11.9% | 1.37% | -1.4% |
| Q3 2022 | $603,000 | -9.5% | 7,934 | +0.8% | 1.39% | +7.8% |
| Q2 2022 | $666,000 | -13.3% | 7,873 | -10.0% | 1.29% | +6.1% |
| Q1 2022 | $768,000 | +4.8% | 8,750 | +4.4% | 1.21% | +12.6% |
| Q4 2021 | $733,000 | +2.7% | 8,380 | -4.1% | 1.08% | -9.2% |
| Q3 2021 | $714,000 | -7.6% | 8,737 | +3.2% | 1.19% | -7.3% |
| Q2 2021 | $773,000 | +14.9% | 8,462 | +7.5% | 1.28% | +11.0% |
| Q1 2021 | $673,000 | -4.3% | 7,872 | +5.7% | 1.15% | -5.6% |
| Q4 2020 | $703,000 | +20.2% | 7,450 | +10.8% | 1.22% | +13.4% |
| Q3 2020 | $585,000 | +2.8% | 6,725 | +3.1% | 1.08% | -3.4% |
| Q2 2020 | $569,000 | +6.0% | 6,520 | 0.0% | 1.12% | -9.9% |
| Q1 2020 | $537,000 | -5.6% | 6,520 | +8.4% | 1.24% | +23.0% |
| Q4 2019 | $569,000 | +7.6% | 6,012 | -1.1% | 1.01% | -0.1% |
| Q3 2019 | $529,000 | +0.8% | 6,080 | +5.7% | 1.01% | +1.2% |
| Q2 2019 | $525,000 | -4.7% | 5,750 | +0.3% | 1.00% | -4.5% |
| Q1 2019 | $551,000 | +13.6% | 5,730 | +1.3% | 1.04% | +1.5% |
| Q4 2018 | $485,000 | -3.0% | 5,655 | -2.6% | 1.03% | +13.3% |
| Q3 2018 | $500,000 | +14.4% | 5,805 | +0.3% | 0.91% | +5.0% |
| Q2 2018 | $437,000 | -5.6% | 5,790 | +1.1% | 0.86% | -7.6% |
| Q1 2018 | $463,000 | -3.7% | 5,725 | 0.0% | 0.94% | +5.6% |
| Q4 2017 | $481,000 | -0.8% | 5,725 | +1.3% | 0.88% | -4.6% |
| Q3 2017 | $485,000 | +8.3% | 5,650 | +5.2% | 0.93% | +4.6% |
| Q2 2017 | $448,000 | +27.3% | 5,370 | +13.2% | 0.89% | +18.9% |
| Q1 2017 | $352,000 | +28.9% | 4,745 | +26.7% | 0.75% | +17.9% |
| Q4 2016 | $273,000 | +13.8% | 3,745 | +23.0% | 0.63% | +3065.0% |
| Q3 2016 | $240,000 | -1.2% | 3,045 | +3.4% | 0.02% | -42.9% |
| Q2 2016 | $243,000 | – | 2,945 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |